Medication

Photo

News • Ivermectin licensing in the UK

Why a much-needed scabies medicine is being kept back

A medicine that could control outbreaks of scabies in the UK is unlicensed and only available through specialist importers, researchers at Brighton and Sussex Medical School (BSMS) have found. In July 2019, the World Health Organization (WHO) updated its model list of essential medicines to include oral ivermectin for scabies-related infections. This recommendation follows the 2017 WHO…

Photo

News • Reduced liver complications

The surprising benefits of anti-hepatitis medicine

A new effective treatment of hepatitis C that was made available to all Danes last year, not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis. This is the result of a new study from Aarhus University and Aarhus University Hospital. Hepatitis C is a serious disease, but the biggest threat to someone’s health is…

Photo

News • Blood thinning 2.0

Developing next generation anticoagulants

A University of Leeds spin-out company has secured £3.14m to develop a next generation drug that aims to prevent blood clots forming, without the risk of bleeding present in currently available drugs. Currently, anticoagulants have a relatively narrow margin between beneficial effects and undesirable bleeding, so new approaches are in demand. These could allow more patients that have a higher…

Photo

News • FDA launches off-label drug database

Cure ID: App finds new ways of treatment

The U.S. Food and Drug Administration (FDA) announced the global launch of Cure ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from…

Photo

News • Disarming MRSA

Potent antimicrobial to fight staph infections

Research led by scientists from McMaster University has yielded a potent antimicrobial that works against the toughest infectious disease strains. The find could be the beginning of developing new therapeutics to combat drug-resistant infections. The discovery is important as it is directly related to the development of Staphylococcus aureus diseases, known popularly as staph infections, which…

Photo

News • Malignant infantile brain tumours

​Epilepsy drug inhibits brain tumour development

Medication prescribed for a certain type of epilepsy may offer a new method for treating malignant infantile brain tumours. A specific mTOR inhibitor has the ability to cross the blood–brain barrier to both reach and attack the tumour at source. This has been demonstrated by researchers from Uppsala University, in collaboration with US and UK colleagues, whose research has now been published in…

Photo

News • Nanoswarm

Tiny transporters deliver treatment to stroke patients

Swarms of nanoparticles which are 15,000 times smaller than a pinhead may be able to deliver vital drugs to the brain, offering new hope to patients in the early stages of a stroke. The research, carried out at The University of Manchester, shows that tiny vesicles called liposomes, just 100 nanometres in diameter can translocate through the damaged blood brain barrier following stroke. And that…

Photo

News • Inhalation visualised

New imaging tech gives insights into pulmonary drug delivery

Inhalation therapy is widely used for the treatment of lung diseases. Targeting of drugs to the site of disease is a major goal to improve drug efficacy and minimize side effects. Scientists at the Helmholtz Zentrum München and the Technical University of Munich have now shown that combined insight from various imaging methods allows for real-time monitoring of the dynamic process of drug…

Photo

News • Meta-analysis

Benefit and risk: drug-coated balloon angioplasty

Scientists of Jena University Hospital, Germany, conducted a meta-analysis to evaluate benefit and risk of paclitaxel-coated balloon angioplasty compared to conventional balloon angioplasty as therapy of intermittent claudication. The study confirms an increased all-cause mortality, which has formerly been stated, and found a broad heterogeneity in the effectivity of the procedure depending on…

Photo

News • EMA recommandation for Ervebo

Ebola: first vaccine to protect against deadly virus

It is an important step towards fighting one of the deadliest viruses known to man: The human medicines committee (CHMP) of the European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation in the European Union for Ervebo (rVSVΔG-ZEBOV-GP), the first vaccine for active immunisation of individuals aged 18 years and older at risk of infection with the Ebola virus.…

Photo

News • Presented at SAC cardiology congress

App reminds heart patients to take their pills

Heart patients using a smartphone app reminder are more likely to take their medication than those who receive written instructions, according to a study presented at the 45th Argentine Congress of Cardiology (SAC 2019) in Buenos Aires. ‘We hypothesised that the app would increase adherence by 30%, but the impact was even greater,’ said study author Dr Cristian M. Garmendia, of the…

Photo

News • Lumacaftor-ivacaftor

Cystic fibrosis patients benefit from drug combination, but...

In adolescent and adult patients with cystic fibrosis (CF) taking lumacaftor-ivacaftor (Orkambi), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. However, the treatment also…

Photo

News • Cognitive chemical manufacturing

‘Lab-bot’ could revolutionise hunt for cancer drugs

A robot-controlled laboratory where decisions are made by artificial intelligence will change the way new drugs are discovered, says a leading researcher. The engineer leading a project to develop a prototype "lab-bot" says it will reduce the time it takes to identify and synthesise molecules for new medicines – a process that can take years as scientists refine the shape and property…

Photo

News • Statins study

How effective is cholesterol medication? New study sheds light

A study by a team of Victoria University of Wellington scientists spotlights the role of gene networks in how people respond to one of the world’s most prescribed medications. The research team investigated the genetic network response to cholesterol-lowering drugs called statins, a medication prescribed to about 30 million people worldwide. The researchers say it is a significant step towards…

Photo

News • Tiny biomaterials

On the way to safer nanomedicine

Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little knowledge thus far about what exactly will happen to nanoparticles within our tissues and whether or not they can cause disease by themselves. Within an international research consortium, Empa scientists have now developed guidelines that should…

Photo

News • Targeted treatment

New nanomedi­cine for efficient cancer chemo­ther­apy

Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University (Finland) and Huazhong University of Science and Technology (China) have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy. This new nano-tool provides a new approach to use cell-based nanomedicines for efficient cancer chemotherapy. Exosomes contain various molecular…

Photo

News • Hypothyroidism

Underactive thyroid: Study validates treatment guidelines

A study led by the University of Birmingham provides strong support for current recommendations on treating patients with an underactive thyroid and validates latest UK and US guidelines, say researchers. The retrospective cohort study, published in The BMJ, analysed anonymous GP records of over 162,000 patients who have been diagnosed with hypothyroidism – a highly prevalent condition more…

Photo

News • Rare lung disease

FDA approval for scleroderma treatment

The U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition. “Patients suffering from scleroderma need effective therapies, and the FDA supports the efforts…

Photo

Video • Mini sunlight reactor

Producing meds with 'artificial leaf' technology

Being able to produce medicines cheaply and everywhere, with sunlight as an energy source. This reality is closer than ever now that chemists from Eindhoven University of Technology are presenting a "mini-reactor" that, similar to leaves in nature, absorbs sunlight and drives chemical reactions. As an ultimate demonstration, they succeeded in having the reactor actually produce two…

Photo

News • Psychological treatment

New PTSD meds take advantage of body's own cannabinoids

A medication that boosts the body’s own cannabis-like substances, endocannabinoids, shows promise to help the brain un-learn fear memories when these are no longer meaningful. This according to an early-stage, experimental study on healthy volunteers at Linköping University. The new findings give hope that a new treatment can be developed for post-traumatic stress disorder, PTSD. “We have…

Photo

News • Food supplementation

Can 'fortified' flour fight vitamin D deficiency?

Adding vitamin D to wheat flour would prevent 10 million new cases of vitamin D deficiency in England and Wales over the next 90 years, say researchers at the University of Birmingham. The researchers say overhauling existing public health policy to introduce the mandatory fortification of vitamin D in wheat flour would not only be cost saving but would significantly reduce the burden on the NHS…

Photo

News • Stem cell regeneration

Drug accelerates recovery after chemo, radiation

A drug developed by US physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the compound could help people recover quicker from chemotherapy, radiation and bone marrow transplants. The study, published in Nature Communications, also sheds light on the basic biology behind blood…

Photo

News • Hidden chemistry

This flower might hold the key to killing cancer cells

Researchers at the University of Birmingham have shown that it’s possible to produce a compound with anti-cancer properties directly from feverfew – a common flowering garden plant. The team was able to extract the compound from the flowers and modify it so it could be used to kill chronic lymphocytic leukaemia (CLL) cells in the laboratory. Feverfew is grown in many UK gardens, and also…

Photo

News • Personalised medicine

Why digital twins could be the ideal therapy testbed

Advanced computer models of diseases can be used to improve diagnosis and treatment. The goal is to develop the models to “digital twins” of individual patients. Those twins may help to computationally identify and try the best medication, before actually treating a patient. The models are the result of an international study, published in the open access journal Genome Medicine.

Photo

News • Elderly in the ICU

Can flu vaccine reduce stroke risk?

It appears that an influenza vaccine does not just work when it comes to influenza. A new study shows that elderly people who have been admitted to an intensive care units have less risk of dying and of suffering a blood clot or bleeding in the brain if they have been vaccinated. And this is despite the fact that they are typically older, have more chronic diseases and take more medicine then…

363 show more articles
Subscribe to Newsletter